Targeting HER2/HER3 co‐mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy.
- Resource Type
- Article
- Source
- Cancer Reports; Mar2024, Vol. 7 Issue 3, p1-12, 12p
- Subject
- Language
- ISSN
- 25738348